Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin‐17 levels in bleomycin‐induced dermal fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin‐17 levels in bleomycin‐induced dermal fibrosis

Published:2021-04-09 Issue: Volume: Page:
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Karatas Ahmet¹,Celik Cigdem²,Oz Burak¹,Akar Zeynel Abidin¹,Etem Ebru Onalan³,Dagli Adile Ferda⁴,Koca Suleyman Serdar¹^ORCID

Affiliation:

1. Department of Rheumatology Faculty of Medicine Firat University Elazig Turkey

2. Department of Internal Medicine Eleskirt State Hospital Agri Turkey

3. Department of Medical Biology Faculty of Medicine Firat University Elazig Turkey

4. Department of Pathology Faculty of Medicine Firat University Elazig Turkey

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.14114

Reference50 articles.

1. Systemic sclerosis

2. Pathophysiology of systemic sclerosis: current understanding and new insights

3. Emerging targets of disease-modifying therapy for systemic sclerosis

4. Targeting Costimulatory Pathways in Systemic Sclerosis

5. T-Cells and B-Cells in Systemic Sclerosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental Insights on the Use of Secukinumab and Magnolol in Acute Respiratory Diseases in Mice;Biomedicines;2024-07-11

2. Targeting Common Inflammatory Mediators in Experimental Severe Asthma and Acute Lung Injury;Pharmaceuticals;2024-03-05

3. Role of regulatory T cells in pathogenesis and therapeutics of scleroderma (systemic sclerosis);Regulatory T Cells and Autoimmune Diseases;2024

4. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study;Rheumatology International;2023-12-05

5. Effects of IL-17 Inhibition with Secukinumab in Experimental Periodontitis;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3